ArticleFrontiers in oncology2026

Case Report: CD19 CAR-T therapy induces durable remission in a pediatric patient with TP53-mutated, refractory Burkitt lymphoma: a 30-month follow-up.

Yong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.